July 2014 webinar: Pharmaceutical implications for underwriters and Pharma management from claims


The overall cost of prescription drugs is increasing at a rapid rate.  Some of the increase is due to price increases; some is due to changes in utilization patterns; some is due to the availability of new drug therapies.

In Asia, insurers have been somewhat insulated from the impact of increasing costs because much of the drug spend is out-of-pocket from the consumer.  Most commonly, drug reimbursement has been limited to the cost of those drugs used during an inpatient stay or for a limited period of time before and after an inpatient event.  But as more comprehensive medical reimbursement plans are being offered, insurers are expanding the scope of pharmaceutical coverage and increasing their exposure to these costs.

This webinar will address the rising costs of drugs and how those costs are currently managed in Asia.  It will cover how drug spend is managed in other healthcare economies and identify those techniques that may hold potential for Asian markets.  Specifically, the webinar will include:

Target group

This webinar is targeted at claim managers, clinical staff, and product managers who have an interest in pharmaceutical benefits.


  • Current market and cost trends
  • An overview of the current status of pharmaceutical management across Asia
  • Key features of global "best practice" pharmaceutical management; what is working in other countries and why
  • Plan design considerations
  • Pharmaceutical cost control programs
  • How global "best practice" can be adapted for Asia; what works, what doesn't
  • Upcoming issues for which to plan, e.g. injectable/biological drugs


  • Presentation – 45 mins
  • Question and answers – 15 mins


Sam Ours
Head of Medical Operations-Asia
Swiss Reinsurance Company


23 July 2014 (Wednesday)


2 - 3 pm, AWST (Hong Kong time)


1 hour





Webinar registration

If you are interested in attending this webinar, please contact your Client Manager´╗┐